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Fig. 1. Immune activation in virologic responders. Percentages of various cell populations and plasma levels of soluble markers in healthy donors (HIV-), treated (HIV+ ART+), and
untreated (HIV+ ART–) HIV patients. Data are presented as mean values and 95% conﬁdence intervals; p-values are shown.
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Fig. 2. Variables factor map resulting from Principal Component Analysis. The variables are represented by arrows. The elbow test was carried out in order to select the number of
components to consider. This was done by plotting the components' eigenvalues according to their size and analyzing the point in the graph where the slope goes from “steep” to
“ﬂat” in order to keep only the components that are placed before the elbow, which were 2 in our case. The length of each of these arrows depends on the correlation of the variable
with the component. Highly positively correlated variables are represented by arrows close to each other. Strongly negatively correlated variables are represented by arrows
diametrically opposed.
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Fig. 3. Virologic responders present with different immune activation proﬁles. Heatmap showing the hierarchical clustering of the activation markers (vertical) as well as of the virologic
responders according to their proﬁle of activation (horizontal). Each group number is indicated.
Fig. 4. Characterization of the ﬁve different immune activation proﬁles. Differences in the levels of key activation markers between each group of patients and the other groups are
represented. Data are presented as mean values and 95% conﬁdence intervals; p-values are shown.
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Fig. 5. Link between immune activation proﬁle 2 and marks of metabolic syndrome. Odd ratios relating each proﬁle of immune activation to risk of hyperinsulinemia (a),
hypertriglyceridemia (b), and lipodystrophy (c). Data are presented as OR and 95% conﬁdence intervals.
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